Form D · Other Investment Fund
Nextech IV Oncology S.C.S. SICAV-SIF
Munsbach, N4 · CIK 0001627788
Offering snapshot reported Dec 11, 2014 · SEC filing
- Reported sold
- $40.1M Offering amount: $150M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 26, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 11, 2014 | Initial | $40,122,250 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $31.4K (estimated)
- Form D file number
- 021-229933
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| SOURCE CAPITAL GROUP | 36719 |
Source: Form D, filed Dec 11, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christoph Kraiker | Executive |
| Marc Kriegsmann | Executive |
| Thomas Lips | Executive |
| N/A Nextech Invest Ag | Promoter |
| N/A Nextech Iv Gp S.A.R.L. | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
1 C, Rue Gabriel Lippmann
Munsbach, N4, L-5365
Munsbach, N4, L-5365